# ResMed Inc. (RMD) stock: price, valuation and fundamentals

URL: https://funkfolio.com/stock/RMD

> ResMed Inc. (RMD) trades at $238.98, is worth $33.61B, is priced at 21.8× earnings and scores 86/100. Valuation, financials and signals.

---

## ResMed Inc. (RMD)

ResMed Inc. (RMD) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $238.98, up 0.33% on the day, which values the company at $33.61B. Price as of 17 Nov 2026, 19:05 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $238.98 +0.33% today
- **Market value:** $33.61B
- **P/E ratio:** 21.8× last 12 months
- **Forward P/E:** 18.1×
- **Dividend yield:** 1.03%
- **Funk Score:** 86/100
- **Against its own history:** About its usual price usual price $261.06
- **200-week average:** $220.56 8% above

Figures as of 17 Nov 2026, 19:05 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### ResMed Inc. in more detail

RMD trades at 21.8× its last twelve months' earnings, 18.1× next year's expected earnings, 5.9× sales. Measured against its own history, the price is 8% below what its usual multiples would imply ($261.06) — about its usual price. It sits 8% above its 200-week average of $220.56.

Over the last five fiscal years ResMed Inc. has compounded revenue 12.1% a year, earnings per share 26.3% a year, free cash flow 20.8% a year. Its Funk Score is 86 out of 100 (financial strength 9.4, profitability 10.0, growth 8.4, value 6.7, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

1 of the superinvestors tracked here hold RMD, including François Rochon (2.8% of the portfolio).

### Superinvestors holding RMD

1 of the investors tracked here report a position in their latest 13F filing.

- [François Rochon Giverny Capital](https://funkfolio.com/gurus/francois-rochon) 2.80% of portfolio · $81.8M · trimmed · Q3 2026

### Health Care companies of similar size

- [Biogen BIIB](https://funkfolio.com/stock/BIIB)
- [GE HealthCare Technologies GEHC](https://funkfolio.com/stock/GEHC)
- [Alcon ALC](https://funkfolio.com/stock/ALC)
- [Mettler-Toledo International MTD](https://funkfolio.com/stock/MTD)
- [Centene CNC](https://funkfolio.com/stock/CNC)
- [Genmab GMAB](https://funkfolio.com/stock/GMAB)
- [Illumina ILMN](https://funkfolio.com/stock/ILMN)
- [Zoetis ZTS](https://funkfolio.com/stock/ZTS)
- [Labcorp Holdings LH](https://funkfolio.com/stock/LH)
- [DexCom DXCM](https://funkfolio.com/stock/DXCM)
- [Koninklijke Philips PHG](https://funkfolio.com/stock/PHG)
- [Roivant Sciences ROIV](https://funkfolio.com/stock/ROIV)

Side by side: [RMD vs ZTS (ResMed Inc. vs Zoetis)](https://funkfolio.com/compare/rmd-vs-zts) [RMD vs ILMN (ResMed Inc. vs Illumina)](https://funkfolio.com/compare/ilmn-vs-rmd) [RMD vs GMAB (ResMed Inc. vs Genmab)](https://funkfolio.com/compare/gmab-vs-rmd) [RMD vs CNC (ResMed Inc. vs Centene)](https://funkfolio.com/compare/cnc-vs-rmd) [RMD vs MTD (ResMed Inc. vs Mettler-Toledo International)](https://funkfolio.com/compare/mtd-vs-rmd)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### ResMed Inc. (RMD): questions and answers

**What is RMD's P/E ratio?**

ResMed Inc. trades at 21.8× its last twelve months' earnings and 18.1× next year's expected earnings. At its fiscal year-ends over the past 17 years the P/E ranged from 18.2× to 76.1×, with a median of 25.4×.

**What is RMD's PEG ratio?**

ResMed Inc.'s PEG ratio is 1.28 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is ResMed Inc.'s market cap?**

ResMed Inc. is valued at $33.61B at a share price of $238.98.

**Is RMD overvalued or undervalued?**

Against its own history, RMD is about its usual price: the price is 8% below the $261.06 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is RMD above its 200-week moving average?**

Yes. RMD is 8.4% above its 200-week average of $220.56. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is ResMed Inc. growing?**

Over the last five fiscal years ResMed Inc.'s revenue grew 12.1% a year and its earnings per share 26.3% a year; over ten years revenue grew 11.9% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “ResMed Inc. (RMD) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/RMD

Underlying data: Yahoo Finance; company filings with the SEC.
